Baxter International, Inc. (BAX)
25.80
+0.06
(+0.25%)
USD |
NYSE |
Nov 13, 16:00
25.80
0.00 (0.00%)
After-Hours: 19:59
Baxter International Shareholders Equity (Quarterly) : 6.502B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 6.502B |
| June 30, 2026 | 6.206B |
| March 31, 2026 | 6.043B |
| December 31, 2025 | 6.129B |
| September 30, 2025 | 7.241B |
| June 30, 2025 | 7.32B |
| March 31, 2025 | 7.081B |
| December 31, 2024 | 6.964B |
| September 30, 2024 | 7.872B |
| June 30, 2024 | 7.643B |
| March 31, 2024 | 8.173B |
| December 31, 2023 | 8.402B |
| September 30, 2023 | 8.101B |
| June 30, 2023 | 5.569B |
| March 31, 2023 | 5.879B |
| December 31, 2022 | 5.833B |
| September 30, 2022 | 5.535B |
| June 30, 2022 | 8.859B |
| March 31, 2022 | 9.075B |
| December 31, 2021 | 9.077B |
| September 30, 2021 | 8.77B |
| June 30, 2021 | 8.494B |
| March 31, 2021 | 8.452B |
| December 31, 2020 | 8.689B |
| September 30, 2020 | 8.567B |
| Date | Value |
|---|---|
| June 30, 2020 | 8.128B |
| March 31, 2020 | 7.699B |
| December 31, 2019 | 7.882B |
| September 30, 2019 | 7.588B |
| June 30, 2019 | 7.812B |
| March 31, 2019 | 7.646B |
| December 31, 2018 | 7.844B |
| September 30, 2018 | 9.13B |
| June 30, 2018 | 8.881B |
| March 31, 2018 | 9.099B |
| December 31, 2017 | 9.124B |
| September 30, 2017 | 9.466B |
| June 30, 2017 | 9.175B |
| March 31, 2017 | 8.686B |
| December 31, 2016 | 8.29B |
| September 30, 2016 | 8.677B |
| June 30, 2016 | 8.509B |
| March 31, 2016 | 9.019B |
| December 31, 2015 | 8.846B |
| September 30, 2015 | 7.824B |
| June 30, 2015 | 7.988B |
| March 31, 2015 | 7.258B |
| December 31, 2014 | 8.12B |
| September 30, 2014 | 8.404B |
| June 30, 2014 | 8.662B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 24.68B |
| Boston Scientific Corp. | 25.63B |
| DexCom, Inc. | 2.535B |
| Abbott Laboratories | 51.03B |
| ICU Medical, Inc. | 2.191B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.41B |
| Total Liabilities (Quarterly) | 12.94B |
| Debt to Equity Ratio | 1.232 |
| Current Ratio | 1.792 |
| Net Debt Paydown Yield | 2.76% |